BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
BGHL (EUR): NAV(s)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Arcoma AB
Fortsatt stark resultatutveckling, EBITDA ökar med 104%
FINANSIELLT SAMMANDRAG Tredje kvartalet • Nettoomsättning för kvartalet ökade med 4% till 30 396 (29 290) kSEK. • EBITDA (rörelseresultat före avskrivningar) steg med 104% till 3...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
BGHL (GBP): NAV(s)
BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
CGG
CGG Announces Largest OBN Multi-Client Survey in UK CNS
CGG Announces Largest OBN Multi-Client Survey in UK CNS Paris, France – 19 November, 2019 CGG announced today a program to deliver the largest OBN multi-client survey ever conducted in the UK...
Sinch AB
Sinch AB (publ): Sinch issues bonds of SEK 750 million
Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH Sinch AB (publ), a global leader in cloud communications for mobile customer engagement, has today successfully issued senior unsecured bonds in the...
Nokia Oyj
Nokia secures 50th 5G deal with Spark New Zealand
Press Release Nokia secures 50th 5G deal with Spark New Zealand Spark New Zealand selects Nokia radio access network technology for its roster of preferred suppliers for its 5G rolloutBrings...
Santhera Pharmaceuticals Holding AG
Santhera Announces Publication of Long-term Idebenone Data from SYROS Study in Duchenne Muscular Dystrophy
Pratteln, Switzerland, November 19, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces publication of the previously reported SYROS study data in prominent peer-reviewed medical journal...
Idorsia Pharmaceuticals Ltd
Idorsia enters into a collaboration with Antares for the development of a novel self-administered drug-device product for selatogrel
• The companies will develop a novel drug-device product combining Idorsia's P2Y12 receptor antagonist, selatogrel, with the Antares QuickShot® auto-injector • Idorsia is preparing for a Phase 3...
ORPHAZYME A/S
Orphazyme receives Breakthrough Therapy Designation for arimoclomol in Niemann-Pick Disease Type C (NPC)
Orphazyme A/SCompany announcement No....
Nokia Oyj
Nokia secures 49th commercial contract by fully supporting DOCOMO PACIFIC to deliver first commercial 5G in the Marianas
Press Release Nokia secures 49th commercial contract by fully supporting DOCOMO PACIFIC to deliver first commercial 5G in the Marianas Nokia is the primary vendor for DOCOMO PACIFIC, the leading...